Free Trial

Zacks Research Comments on Avantor's Q3 Earnings (NYSE:AVTR)

Avantor logo with Medical background

Avantor, Inc. (NYSE:AVTR - Free Report) - Analysts at Zacks Research raised their Q3 2025 earnings estimates for Avantor in a note issued to investors on Tuesday, May 27th. Zacks Research analyst R. Department now forecasts that the company will earn $0.27 per share for the quarter, up from their prior forecast of $0.26. The consensus estimate for Avantor's current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor's Q4 2025 earnings at $0.28 EPS and FY2025 earnings at $1.03 EPS.

A number of other equities analysts also recently commented on AVTR. Citigroup reduced their target price on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Cowen downgraded shares of Avantor from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Wells Fargo & Company reduced their target price on shares of Avantor from $25.00 to $22.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. TD Cowen downgraded shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price for the company. in a report on Monday, April 28th. Finally, Stifel Nicolaus downgraded shares of Avantor from a "buy" rating to a "hold" rating and reduced their target price for the stock from $26.00 to $14.00 in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Avantor has a consensus rating of "Hold" and a consensus price target of $18.88.

Get Our Latest Stock Analysis on Avantor

Avantor Stock Down 1.0%

NYSE:AVTR traded down $0.13 during mid-day trading on Friday, reaching $12.91. The company's stock had a trading volume of 11,443,298 shares, compared to its average volume of 7,958,956. The firm has a market capitalization of $8.80 billion, a PE ratio of 12.41, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The stock has a fifty day moving average of $14.08 and a 200-day moving average of $17.96. Avantor has a 1 year low of $11.82 and a 1 year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, hitting analysts' consensus estimates of $0.23. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the prior year, the firm earned $0.22 earnings per share. The firm's revenue for the quarter was down 5.9% compared to the same quarter last year.

Institutional Trading of Avantor

A number of hedge funds have recently added to or reduced their stakes in AVTR. Rise Advisors LLC purchased a new stake in Avantor during the first quarter worth $25,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Avantor by 288.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company's stock worth $28,000 after buying an additional 1,263 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after buying an additional 830 shares in the last quarter. Wealthquest Corp purchased a new stake in Avantor during the first quarter worth $34,000. Finally, Global Retirement Partners LLC boosted its holdings in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In other Avantor news, Director Gregory L. Summe acquired 30,000 shares of the company's stock in a transaction dated Friday, May 23rd. The shares were acquired at an average cost of $12.50 per share, with a total value of $375,000.00. Following the acquisition, the director now directly owns 100,000 shares of the company's stock, valued at approximately $1,250,000. The trade was a 42.86% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph R. Massaro purchased 8,100 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were purchased at an average cost of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the acquisition, the director now directly owns 35,038 shares of the company's stock, valued at $430,967.40. This represents a 30.07% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 83,100 shares of company stock worth $1,027,630. 1.20% of the stock is owned by corporate insiders.

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

See Also

Earnings History and Estimates for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines